Cited by 67Endometriosis Research and TreatmentOvarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments

Understanding malignant transformation of endometriosis: Imaging features with pathologic correlation

Robinson, Kristin A., Menias, Christine O., Chen, Longwen, Schiappacasse, Giancarlo, Shaaban, Akram M., Caserta, Melanie P., Elsayes, Khalid M., VanBuren, Wendaline M. +1 more·2020·Abdominal Radiology

Abstract

Purpose Transformation of benign endometriosis to endometriosis-associated ovarian carcinoma (EAOC) is rare; however, women with endometriosis are four times more likely to develop EAOC which can present 20 years earlier than de novo ovarian cancer. Presenting symptoms are often vague and the radiologist's role in recognizing EAOC is critical for early detection and treatment. Histopathologic evaluation remains the mainstay for definitive diagnosis.Methods Using a case-based approach, this article will review the sonographic, CT, and MRI features of EAOC with an emphasis on MRI. Histopathologic correlation of benign and malignant endometriosis will be reviewed.Results Multiple factors contribute to the malignant transformation of endometriosis including genetic alterations, hormonal influences, oxidative stress, and inflammation. Malignancy most often occurs in ovarian endometriomas with less common sites involving the rectovaginal septum, rectosigmoid colon, and abdominal wall scars. The most common pathologic subtypes are endometrioid adenocarcinoma and clear cell carcinoma. MRI is the most specific imaging modality for evaluating EAOC. Key MR features include solid enhancing nodules (accentuated by subtraction imaging), nodular septations, loss of T2 shading within the endometrioma, and diffusion restriction.Conclusions EAOC is a distinct disease that affects women with benign endometriosis at younger ages than classic ovarian cancer. Understanding the imaging features of malignant transformation of endometriosis is essential for early diagnosis and timely definitive treatment.

Integrity signals

Registry

Crossref · 10.1007/s00261-019-01914-7

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Molecular predictors of malignant transformation could exist as genetic alterations, such as mutations in PTEN, ARID1, BAF250a and p53, which have been found in both endometriosis-associated malignancy and endometriosis.

    “Lastly, molecular predictors of malignant transformation could exist as genetic alterations, and as a loss of heterozygosity, such as mutations in PTEN, ARID1, BAF250a and p53, which have been found in both endometriosis-associated malignancy and endometriosis [47,48].”
  • Fibroblast growth factor (FGF-1) and interleukine 1 (IL1) are expressed in both endometriosis and ovarian cancer, suggesting a common mechanism of action towards the malignant transformation.

    “Fibroblast growth factor (FGF-1) and interleukine 1 (IL1) are also expressed in both endometriosis and ovarian cancer, suggesting a common mechanism of action towards the malignant transformation [48].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Robinson, K. A., Menias, C. O., Chen, L., Schiappacasse, G., Shaaban, A. M., Caserta, M. P., Elsayes, K. M., VanBuren, W. M., & Bolan, C. W.
Affiliations
  • Mayo Clinic Hospital (US)
  • Universidad del Desarrollo (CL)
  • University of Utah (US)
  • Mayo Clinic in Florida (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Mayo Clinic (US)
Corresponding author
Robinson, Kristin A.
Venue
Abdominal Radiology
Published
2019-04-02
Volume
45
Issue
6
Pages
1762-1775
ISSN
  • 2366-004X (ISSN-L)
  • 2366-0058
OpenAlex
W2932128083
Cited by
67
References
51
Citations by year
2026: 6 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 8 · 2021: 5 · 2020: 13 · 2019: 1
FWCI
6.47
Type
journal article
Language
en
Open access
closed
Locations
  • Abdominal Radiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
malignant transformation of endometriosis, endometrioma, MRI findings, restricted diffusion, subtraction imaging, endometrioid carcinoma, clear cell carcinoma, histopathological correlation, early detection, ovarian cancer
MeSH terms
Cell Transformation, Neoplastic, Endometriosis, Female, Humans, Ovarian Neoplasms, Adenocarcinoma, Clear Cell, Carcinoma, Endometrioid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review